FUJIFILM Irvine Scientific, Inc. opened its new manufacturing facility in Tilburg, the Netherlands. The facility provides state-of-the-art Life Science manufacturing and joins locations in the U.S. and Japan to enable increased production capacity of cell culture media products. This third manufacturing facility serves as a hub for both European and global markets.
 
The facility’s location in central Europe provides a source of local supply for increased efficiency and cost-savings in shipping, as well as securing the supply chain.
 
The facility is built with sustainable initiatives working towards a CO2-neutral status, using wind energy for the production process, and using sustainable technologies such as membrane bioreactors for wastewater purification.
 
The 13,500 square meter facility was previously used to manufacture film rolls. The facility manufactures dry powder media, liquid media, buffers, and Water for Injection (WFI) in accordance with the same Quality System and raw materials used in the Company’s facilities in the U.S. and Japan. Initially, it increases the Company’s production capacity with approximately 320,000 kg/year of dry powder media and greater than 470,000 L/year of liquids with the physical capacity to expand rapidly.
 
“We worked steadily to achieve milestones for construction, validation, and commissioning of this manufacturing facility,” said Yutaka Yamaguchi, chairman, and chief executive officer, FUJIFILM Irvine Scientific. “Even with the global challenges faced in recent years, FUJIFILM Irvine Scientific was determined to provide customers in Europe with local service that strengthens the supply chain and increases manufacturing capacity. It is extremely rewarding to see this commitment realized.”